Related Experiment Videos
Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies
Amit Panwalkar1, Srdan Verstovsek, Francis Giles
1Section of Developmental Therapeutics, Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Cancer
|April 10, 2004
Summary
Nuclear factor-kappaB (NF-kappaB) is a transcription factor regulating gene expression. Its activation is crucial for cell survival and implicated in hematologic disorders, making NF-kappaB modulation a promising therapeutic target.
Area of Science:
- Molecular Biology
- Cellular Biology
- Immunology
Background:
- Nuclear factor-kappaB (NF-kappaB) is a transcription factor family regulating genes involved in growth, inflammation, and survival.
- NF-kappaB typically exists as an inactive cytoplasmic complex with IkappaB inhibitors.
- Activation by various stimuli releases NF-kappaB for nuclear translocation and gene transcription.
Purpose of the Study:
- To provide an overview of NF-kappaB function and its role in cellular processes.
- To highlight the significance of NF-kappaB in hematologic disorders.
- To discuss the therapeutic potential of NF-kappaB modulation.
Main Methods:
- Literature review of NF-kappaB signaling pathways.
- Analysis of NF-kappaB's role in gene expression.
- Discussion of clinical implications and therapeutic strategies.
Main Results:
- NF-kappaB controls expression of key genes including growth factors and antiapoptotic proteins.
- Constitutive NF-kappaB activation is observed in certain hematologic malignancies.
- NF-kappaB pathway modulation is an emerging therapeutic strategy.
Conclusions:
- NF-kappaB plays a critical role in cell survival and is implicated in disease pathogenesis.
- Targeting the NF-kappaB pathway offers potential therapeutic benefits for hematologic disorders.
- The approval of bortezomib underscores the clinical relevance of NF-kappaB modulation.